Dr. med. Joachim Springub Facharzt fuer Neurologie u. Psychiatrie Zusatzbezeichnung Psychotherapie Wolfgang Schwarz Facharzt fuer Neurologie Zusatzbezeichnung Psychotherapie Partnerschaft — Clinical Trial Site

9 Registered trials

2 Currently recruiting

Organisation

Dr. med. Joachim Springub Facharzt fuer Neurologie u. Psychiatrie Zusatzbezeichnung Psychotherapie Wolfgang Schwarz Facharzt fuer Neurologie Zusatzbezeichnung Psychotherapie Partnerschaft

Location

Westerstede, Germany

Identifier

ORG-100043171

Address

Lange Strasse 25, 26655, Germany

Departments

Gemeinschaftspraxis für Neurologie und Psychiatrie
N/A
Not applicable
Privatpraxis Dr. med. J. Springub, Studienzentrum Nord-West
Studienzentrum Nord-West
Studienzentrum Nordwest

Clinical trials at this site (9)

Search interface

A Study Providing Continued Access to Treatment in Patients with a Neurological Disease Previously Enrolled in a Genentech and/or F. Hoffman… Not authorised

2023-507633-21-00 Neurological Disease 5
A Study Evaluating the Patient Perspective of the Physical Impact of Multiple Sclerosis and Providing Continued Access to Treatment in Patie… Recruiting

2023-507633-21-01 Multiple Sclerosis 5 2024-12-09
A Phase 3, prospective, randomized, double-blind, placebo-controlled, parallel group, international, multi-center study of rotigotine in com… Recruiting

2023-504602-11-00 Mild to moderate Alzheimer's disease 5 2023-10-25
A Study to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Preventive Treatment of Menstrual Migraine Ended

2024-512946-41-00 Menstrual Migraine 5 2025-03-05
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events and Disease Activity in Adult Participants With Migraine… Ended

2022-501172-25-00 Chronic and Episodic Migraine 5 2024-01-17
A clinical trial to investigate efficacy and safety of NT 201 injections compared with placebo injections in participants aged 18 years and … Ended

2022-501461-52-00 Moderate to severe chronic peripheral neuropathic pain 4 2023-10-17
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache Ended

2024-510729-24-00 Chronic Migrane, Migrane, Medication Overuse Headache 6 2022-09-01
A study to test long-term safety of Iclepertin in people with schizophrenia who took part in a previous CONNEX study Ended

2024-511560-93-00 Schizophrenia 5 2022-03-29
Phase 3 Open label clinical trial with oral Atogepant for the prevention of migraine Ended

2023-507096-21-00 Chronic or Episodic Migraine (Migraine without aura, mi 5 2021-08-16